Jump to content
Jump to navigation
Impact & ESG Report 2025
Corporate site
Impact & ESG Report 2025
Corporate site
Home
Introduction
Introduction
Introduction
A message from our Managing Partners
Forbion at a glance
2025 year in review
Our responsible investment journey
Our strategies
Our strategies
Our strategies
Our investment strategies
Human Health: Life Sciences
Human Health: Life Sciences
Human Health: Life Sciences
Portfolio impact highlights 2025
In focus: Rare diseases as catalyst for innovation
Portfolio ESG highlights 2025
Planetary Health: BioEconomy
Planetary Health: BioEconomy
Planetary Health: BioEconomy
Portfolio impact highlights 2025
In focus: Genomines
Portfolio ESG highlights 2025
Our company
Our company
Our company
Our people
Our carbon footprint
Looking ahead
Downloads
Downloads
Introduction
Our strategies
Our company
Our company
Our company
In this section
Our people
Our carbon footprint
Looking ahead
Previous page
Portfolio ESG highlights 2025
Next page
Our people
